Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agents
Abdelsattar M. Omar(Al-Azhar University), Martin K. Safo(Virginia Commonwealth University), Mohini S. Ghatge(Children's Hospital of Philadelphia), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Asala H. Naghi(King Abdulaziz University), Moustafa E. El‐Araby(King Abdulaziz University), Piyusha P. Pagare(Virginia Commonwealth University), Akul Y. Mehta(Hadassah Medical Center), Qiongxia Chen(Children's Hospital of Philadelphia), Tanya David(Children's Hospital of Philadelphia), Y Zhang(University of Richmond)
Cited by 9
Related Papers
In vivo hematopoietic stem cell modification by mRNA delivery
|Science|2023|321
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>†,‡</sup>
|British Journal of Haematology|2005|244
Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia
|Nature Communications|2016|212
GlyGen: Computational and Informatics Resources for Glycoscience
|Glycobiology|2019|207